Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Controversies in COX-2 selective inhibition.
Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH. Simon LS, et al. J Rheumatol. 2002 Jul;29(7):1501-10. J Rheumatol. 2002. PMID: 12136912 Review. No abstract available.
COX-2 selective inhibitors and heart health.
Simon LS, White WB. Simon LS, et al. Postgrad Med. 2005 Jan;117(1 Suppl):7-20. doi: 10.3810/pgm.01.2005.suppl40.201. Postgrad Med. 2005. PMID: 19667717 Review.
How to ascertain drug safety in the context of benefit. Controversies and concerns.
Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, Saag KG, Silman AJ, Stevens R, Tyndall A. Simon LS, et al. J Rheumatol. 2009 Sep;36(9):2114-21. doi: 10.3899/jrheum.090591. J Rheumatol. 2009. PMID: 19738223
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
Lipsky PE, Abramson SB, Breedveld FC, Brook P, Burmester R, Buttgereit F, Cannon GW, Catella-Lawson F, Crofford LJ, Doherty M, Dougados M, DuBois RN, Froelich J, Garcia Rodriguez LA, Gibofsky A, Hernandez-Diaz S, Hochberg MC, Krause A, Liang MH, Machold K, Peloso PM, Raisz LG, Schayes B, Scheiman JM, Simon LS, Smolen J. Lipsky PE, et al. Among authors: simon ls. J Rheumatol. 2000 Jun;27(6):1338-40. J Rheumatol. 2000. PMID: 10852251 No abstract available.
The classification of cyclooxygenase inhibitors.
Lipsky LP, Abramson SB, Crofford L, Dubois RN, Simon LS, van de Putte LB. Lipsky LP, et al. Among authors: simon ls. J Rheumatol. 1998 Dec;25(12):2298-303. J Rheumatol. 1998. PMID: 9858421 Review.
Minimal disease activity for rheumatoid arthritis: a preliminary definition.
Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS. Wells GA, et al. Among authors: simon ls. J Rheumatol. 2005 Oct;32(10):2016-24. J Rheumatol. 2005. PMID: 16206362
238 results